Table of Contents 3
List of Tables 5
List of Figures 5
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CTI BioPharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Cell Therapeutics Acquires Pacritinib From S*BIO 11
Venture Financing 13
CTI BioPharma Announces Venture Debt Financing 13
Licensing Agreements 14
CTI BioPharma Enters into Licensing Agreement with Vernalis for tosedostat 14
Servier Expands Licensing Agreement with CTI BioPharma for Pixuvri 15
Equity Offering 17
CTI BioPharma to Raise up to USD50 Million in Public Offering of Shares 17
CTI BioPharma Raises USD69 Million in Public Offering of Shares 18
CTI BioPharma Raises USD45 Million in Public Offering of Series N-3 Preferred Stock 20
CTI BioPharma Raises USD55 Million in Public Offering of Series N-2 Preferred Stock 22
CTI BioPharma Raises USD50 Million in Public Offering of Shares 24
CTI BioPharma Raises USD15.7 Million in Private Placement of Shares 26
CTI BioPharma Raises USD35 Million in Public Offering of Preferred Shares 28
Cell Therapeutics Completes Private Placement Of Preferred Stock For US$15 Million 30
Cell Therapeutics Completes Public Offering Of Preferred Stock For US$60 Million 32
Cell Therapeutics Completes Second Tranche Of Private Placement Of Series 15-2 Convertible Preferred Stock For US$15 Million 34
CTI BioPharma Corp - Key Competitors 36
CTI BioPharma Corp - Key Employees 37
CTI BioPharma Corp - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Nov 01, 2018: CTI BioPharma reports third quarter 2018 financial results 39
Aug 02, 2018: CTI BioPharma reports second quarter 2018 financial results 40
May 03, 2018: CTI BioPharma Reports First Quarter 2018 Financial Results 42
Mar 07, 2018: CTI BioPharma Reports Fourth Quarter and Full Year 2017 Financial Results 43
Nov 06, 2017: CTI BioPharma Reports Third Quarter 2017 Financial Results 45
Aug 03, 2017: CTI BioPharma Reports Second Quarter 2017 Financial Results 46
May 03, 2017: CTI BioPharma Reports First Quarter 2017 Financial Results 47
Mar 02, 2017: CTI BioPharma Reports Fourth Quarter and Full Year 2016 Financial Results 48
Corporate Communications 50
Sep 26, 2017: CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions 50
Jul 24, 2017: CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors 51
Jun 05, 2017: CTI BioPharma Appoints David R. Parkinson, M.D., Leader in Oncology Clinical Development, to Board of Directors and Announces Board Member Resignations 52
Feb 27, 2017: CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO 53
Product News 54
01/09/2017: CTI BioPharma Announces Progress Of Pacritinib And Strategic Objectives For 2017 54
Product Approvals 56
Mar 24, 2017: Withdrawal of the marketing authorisation application for Enpaxiq (pacritinib) 56
Clinical Trials 57
Jan 05, 2017: CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib 57
Other Significant Developments 59
Jan 25, 2018: CTI BioPharma Provides Corporate and European Regulatory Update 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CTI BioPharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CTI BioPharma Corp, Deals By Therapy Area, 2012 to YTD 2018 9
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cell Therapeutics Acquires Pacritinib From S*BIO 11
CTI BioPharma Announces Venture Debt Financing 13
CTI BioPharma Enters into Licensing Agreement with Vernalis for tosedostat 14
Servier Expands Licensing Agreement with CTI BioPharma for Pixuvri 15
CTI BioPharma to Raise up to USD50 Million in Public Offering of Shares 17
CTI BioPharma Raises USD69 Million in Public Offering of Shares 18
CTI BioPharma Raises USD45 Million in Public Offering of Series N-3 Preferred Stock 20
CTI BioPharma Raises USD55 Million in Public Offering of Series N-2 Preferred Stock 22
CTI BioPharma Raises USD50 Million in Public Offering of Shares 24
CTI BioPharma Raises USD15.7 Million in Private Placement of Shares 26
CTI BioPharma Raises USD35 Million in Public Offering of Preferred Shares 28
Cell Therapeutics Completes Private Placement Of Preferred Stock For US$15 Million 30
Cell Therapeutics Completes Public Offering Of Preferred Stock For US$60 Million 32
Cell Therapeutics Completes Second Tranche Of Private Placement Of Series 15-2 Convertible Preferred Stock For US$15 Million 34
CTI BioPharma Corp, Key Competitors 36
CTI BioPharma Corp, Key Employees 37
CTI BioPharma Corp, Subsidiaries 38

List of Figures
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CTI BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9